New immune modulatory drugs for systemic lupus erythematosus - What can we expect?

Nature Clinical Practice Rheumatology

Volumn 2, Issue 12, 2006, Pages 638-639

  Davidson, Anne ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALPHA INTERFERON; CD22 ANTIGEN; CD28 ANTIGEN; CD40 LIGAND; CHEMOKINE; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETANERCEPT; IMMUNOMODULATING AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INFLIXIMAB; INTERLEUKIN 6; PREDNISONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

B LYMPHOCYTE; CELL SURVIVAL; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; ENZYME INDUCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

HUMANS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; TREATMENT OUTCOME;

EID: 33751523267     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0301     Document Type: Review

References (10)

1. Wakeland EK et al. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408
2. Sharif MN et al. (2004) IFN-alpha priming results in a gain of proinflammatory function by IL-10: Implications for systemic lupus erythematosus pathogenesis. J Immunol 172: 6476-6481
3. Davidson A et al. (2005) Block and tackle: CTLA4Ig takes on lupus. Lupus 14: 197-203
4. Schiffer L et al. (2003) Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 171: 489-497
5. Aringer M et al. (2004) Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: An open-label study. Arthritis Rheum 50: 3161-3169
6. Theofilopoulos AN et al. (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336
7. Nestle FO et al. (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202: 135-143
8. Ramanujam M et al. (2006) Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest 116: 724-734
9. Goodnow CC (2006) Immunology. Discriminating microbe from self suffers a double toll. Science 312: 1606-1608
10. Lagakos SW (2006) The challenge of subgroup analyses - reporting without distorting. N Engl J Med 354: 1667-1669